Posts by: Margarida Azevedo

Margarida Azevedo

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

June 14, 2016June 14, 2016

Scientists Create 2 Molecules with Potential to Counter Antibiotic Resistance

Two tiny molecules created by researchers using carbon nanodots as scaffolds found that the nanodots increase antimicrobial efficacy, and the molecules make existing antibiotics more effective, even against such resistant pathogens as ... Read more

June 13, 2016June 13, 2016

Breath Test May Help to Assess Need for Antibiotics in Treating Ventilator-Associated Pneumonia

Researchers at the Zhejiang University conducted a pilot study to validate a simple breath test that could help clinicians diagnose and correctly distinguish a bacterial infection from bacterial colonization. The ... Read more

June 7, 2016

FDA Approves Supplemental NDA of Allergan’s Teflaro for Children with Pneumonia

The U.S. Food and Drug Administration (FDA) has approved Allergan’s supplemental New Drug Application (sNDA) for Teflaro (ceftaroline fosamil). The approval will result in new indications for pediatric patients ages 2 ... Read more

May 31, 2016May 31, 2016

Japanese Phase 2 Pneumonia (CABP) Trial for Cempra’s Solithromycin Yields Positive Results

Cempra Inc., a clinical-stage pharma focused on the development of antibiotics for difficult-to-treat bacterial infectious diseases, announced positive results from a Phase 2 clinical trial on community-acquired bacterial pneumonia (CABP) ... Read more

May 27, 2016May 27, 2016

Diabetes a Risk Factor for Community-Acquired Pneumonia, Research Suggests

Researchers at several Portuguese clinical and research institutions have found that patients with diabetes mellitus are more likely to develop community-acquired pneumonia, experience longer hospitalization periods, and have higher mortality ... Read more

May 26, 2016May 26, 2016

Kids Injured in Vehicle Crashes at Higher Risk of Pneumonia If Treated at Adult Trauma Centers

Researchers from Children’s Hospitals and Clinics of Minnesota compared the clinical and survival outcomes of children and adolescents injured in motor vehicle accidents treated at a stand-alone Level I pediatric trauma ... Read more

May 24, 2016May 24, 2016

Philips’ Children’s Pneumonia Diagnosis Device to Be Scaled Up in Developing Countries Through Collaborative Effort

Leading health technology company Royal Philips and Grand Challenges Canada, which is funded by the Canadian government, recently announced a partnership to scale the manufacturing and distribution of the Philips Children’s ... Read more

May 9, 2016May 9, 2016

New Study Shows Aspiration Pneumonia Leads to Longer and Costlier Hospitalizations in Children

Researchers at Boston Children’s Hospital recently compared the clinical and hospitalization outcomes in children with aspiration pneumonia and with community-acquired pneumonia, and found that children with aspiration pneumonia are more likely to have ... Read more